(Q48420736)

11 February 2018

title

Advances in molecular imaging for the diagnosis of dementia. (English)

1 reference

11 February 2018

main subject

florbetaben f-18

1 reference

ChEBI release 2020-05-28

1

1 reference

11 February 2018

Colin L. Masters

7

object named as

Colin L Masters

1 reference

11 February 2018

Michelle T Fodero-Tavoletti

2

1 reference

11 February 2018

Yukitsuka Kudo

3

1 reference

11 February 2018

Christopher C Rowe

4

1 reference

11 February 2018

Shozo Furumoto

5

1 reference

11 February 2018

Hiroyuki Arai

6

1 reference

11 February 2018

Kazuhiko Yanai

8

1 reference

11 February 2018

Victor L Villemagne

9

1 reference

11 February 2018

language of work or name

English

0 references

publication date

29 July 2009

1 reference

11 February 2018

Expert Opinion on Medical Diagnostics

published in

1 reference

11 February 2018

volume

3

1 reference

11 February 2018

issue

6

1 reference

11 February 2018

page(s)

705-716

1 reference

11 February 2018

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Role of neuroimaging in Alzheimer's disease, with emphasis on brain perfusion SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Differentiation of dementia with Lewy bodies from Alzheimer's disease using Mini-Mental State Examination and brain perfusion SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Current and future uses of neuroimaging for cognitively impaired patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Imaging of cholinergic and monoaminergic neurochemical changes in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

The cholinergic hypothesis of geriatric memory dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdin-4-yl propionate ([11C]PMP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

In vivo visualization of donepezil binding in the brain of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

The quest for Eldorado: development of radioligands for in vivo imaging of nicotinic acetylcholine receptors in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Relationship between nicotinic receptors and cognitive function in early Alzheimer's disease: a 2-[18F]fluoro-A-85380 PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

On the physiological relevance of muscarinic acetylcholine receptors in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Imaging of muscarinic receptors in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Imaging of the dopaminergic system in differential diagnosis of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

In-vivo measurement of activated microglia in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Microglial activation and amyloid deposition in mild cognitive impairment: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

PET imaging of the peripheral benzodiazepine receptor: monitoring disease progression and therapy response in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

The cause of neuronal degeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

La lunga attesa: towards a molecular approach to neuroimaging and therapeutics in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

PET of brain amyloid and tau in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Comparison of 18F-FDG and PiB PET in cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Imaging beta-amyloid burden in aging and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Imaging amyloid deposition in Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Abeta amyloid deposition in the language system and how the brain responds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

PET imaging of amyloid deposition in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting beta-amyloid plaques in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17530050903133790

10.1517/17530050903133790

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

23496052

1 reference

11 February 2018